Skip to main content
. 2018 Mar 23;19(2):271–279. doi: 10.4142/jvs.2018.19.2.271

Table 2. Variability and limitation of application by vaccine matching of globally available vaccines for type O FMDV occurring in Korea during 2010–2014.

graphic file with name jvs-19-271-i002.jpg

FMDV, foot-and-mouth disease virus; FMD, foot-and-mouth disease; SEA, South-East Asia; ME-SA, Middle East and South Asia; NA, not available; -, not tested. *Values were calculated by division between the viral titers (serum titer against viruses used for cross virus neutralization test/serum titer against vaccine viruses in the vaccination groups). Tested by World Reference Laboratory for FMD (Pirbright Institute), UK except an indication note. Tested by MSD Animal Health (FMD vaccine manufacturer). §Tested by Merial Boehringer Ingelheim (FMD vaccine manufacturer). Tested by World Organisation for Animal Health (OIE) Regional Reference Laboratory for FMD (ARRIAH), Russia. Tested by OIE Reference Laboratory for FMD (SENASA), Argentina.